The story of artesunate–mefloquine (ASMQ), innovative partnerships in drug development: case study

BACKGROUND: The Drugs for Neglected Diseases initiative (DNDi) is a not-for profit organization committed to providing affordable medicines and access to treatments in resource-poor settings. Traditionally drug development has happened “in house” within pharmaceutical companies, with research and de...

Descripción completa

Detalles Bibliográficos
Autores principales: Wells, Susan, Diap, Graciela, Kiechel, Jean-René
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Case Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3640935/
https://www.ncbi.nlm.nih.gov/pubmed/23433060
http://dx.doi.org/10.1186/1475-2875-12-68

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3640935/
https://www.ncbi.nlm.nih.gov/pubmed/23433060
http://dx.doi.org/10.1186/1475-2875-12-68

Ejemplares similares